DEERFIELD, Ill.–(BUSINESS WIRE)–TerSera Therapeutics LLC announced today the presentation of new real-world analyses on the treatment patterns of goserelin in women with breast cancer. The data were presented in a poster session at the 2024 American Society of Clinical Oncology (ASCO) Quality Care Symposium, held September 27th and 28th in San Francisco, CA.1 A copy of the poster is available here. The goal of this study was to demonstrate the characteristics of US patients with a diagnosis o
Home › RSS › TerSera® Presents Real-World Evidence on Treatment Patterns of Goserelin (ZOLADEX®) in Women with Breast Cancer at the 2024 American Society of Clinical Oncology (ASCO) Quality Care Symposium